Medical Innovation Exchange

Alnylam, Regeneron hit go on phase 2 trial of genetic NASH therapy after generating signs of efficacy

https://www.fiercebiotech.com/biotech/alnylam-regeneron-hit-go-phase-2-trial-genetic-nash-therapy-after-generating-signs-efficacy

Leave a Comment

Your email address will not be published.

Leave the field below empty!